metal-organic compounds
catena-Poly[[(pyrazine-2-carboxamide-κN4)copper(I)]-μ3-iodido]
aComenius University, Faculty of Natural Sciences, Department of Inorganic Chemistry, Mlynská dolina CH2, 842 15 Bratislava, Slovak Republic
*Correspondence e-mail: krivosudskyl@fns.uniba.sk
In the title metal–organic polymeric complex, [CuI(C5H5N3O)]n, the is composed of one of the polymer and one CuI atom linked to one iodide anion and one pyrazine-2-carboxamide molecule. The CuI atom is in a distorted tetrahedral coordination completed by one pyrazine N atom of the pyrazine-2-carboxamide ligand and three iodide anions. The polymeric structure adopts a well-known ladder-like motif of {CuNI3} tetrahedra running in the b-axis direction. The molecules of the organic ligand are connected via medium-to-strong N—H⋯O and N—H⋯N hydrogen bonds and weak π–π interactions [the distance between two parallel planes of the rings is 3.5476 (14) Å and the centroid–centroid contact is 4.080 (2) Å]. The title compound has a relatively high decomposition temperature (564 K) as a result of relatively strong covalent and non-covalent interactions inside and between the chains.
CCDC reference: 885829
Related literature
For other CuI coordination polymers, see: Peng et al. (2006, 2010); Feng et al. (2006); Wu et al. (2005); Rath & Holt (1985); Rath et al. (1986). For complexes of pyrazine-2-carboxamide with other transition metals and studies of their biological activity, see: Somoskovi et al. (2004); Singh & Seth (1975); Azizov et al. (1978). For other CuI complexes of pyrazine-2-carboxamide, see: Munakata et al. (1997); Goher & Mautner (1999, 2000, 2001). For a description of the Cambridge Structural Database, see: Allen (2002). For non-covalent interactions, see: Bernstein et al. (1995); Bondi (1964); Janiak (2000); Jia et al. (2009); Wells (1975). For the riding constraints used in the see: Cooper et al. (2010).
Experimental
Crystal data
|
Refinement
|
|
Data collection: CrysAlis PRO (Agilent, 2012); cell CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SUPERFLIP (Palatinus & Chapuis, 2007); program(s) used to refine structure: CRYSTALS (Betteridge et al., 2003); molecular graphics: DIAMOND (Brandenburg, 1999), Mercury (Macrae et al., 2006) and ORTEP-3 for Windows (Farrugia, 2012); software used to prepare material for publication: CRYSTALS, PLATON (Spek, 2009) and publCIF (Westrip, 2010).
Supporting information
CCDC reference: 885829
https://doi.org/10.1107/S1600536814013695/vn2084sup1.cif
contains datablock I. DOI:Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S1600536814013695/vn2084Isup2.hkl
Supporting information file. DOI: https://doi.org/10.1107/S1600536814013695/vn2084Isup3.mol
All reactants except copper(I) iodide were obtained commercially and used without further purification. Copper(I) iodide was prepared as follows: Cu(NO3)2.3H2O (12.7 g, 52.5 mmol) was dissolved in 270 ml of distilled water and the solution was cooled until below room temperature. Na2S2O3.5H2O (13.03 g, 52.5 mmol) and KI (9.6 g, 57.8 mmol, 10% excess) were dissolved in 20 ml of distilled water and added slowly into the solution of copper(II) nitrate. The resulting mixture was heated for 20 minutes, cooled to room temperature and filtered. The product was washed with 50 ml of distilled water, 20 ml of ethanol and 20 ml of acetone. Yield: 9.4 g, 94%.
Synthesis of the [Cu(µ3-I)(C5H5N3O)]n (I): CuI (1 g, 5.25 mmol) was dissolved in 50 ml of 3.5 M solution of KI. Pyrazine-2-carboxamide (0.6464 g, 5.25 mmol) was added and the solution was boiled. The almost clear solution was filtered quickly and boiled again. The solution was slowly cooled to room temperature and placed in a refrigerator for 20 minutes. Fine red needle crystals of (I) were filtered, washed with distilled water (50 ml), ethanol (10 ml) and diethylether (10 ml). Yield 1.33 g, 80.8%.
Copper was determined gravimetrically as CuO. C, H and N were estimated on a CHN analyser Vario MICRO cube. Analysis calculated for C5H5N3O1I1Cu1 (found): C 19.15 (19.52), H 1.61 (1.43), N 13.40 (13.68), Cu 20.27 (19.91).
FT—IR spectra were obtained using an FT—IR Nicolet Magna 750 spectrophotometer. The IR spectrum of prepared compound exhibits characteristic bands of pyrazine-2-carboxamide: 3374(s) - νas(NH2), 3161(s) - νs(NH2), 1612(s) - ν(NH2), 1101(w) - δ(NH2), 1376(s) - amide, 1706(s) - ν(C=O), 529(m) - δ(OCN) (Goher & Mautner, 2000).
The thermal decomposition of the substance has been studied under controlled heating at a rate of 5°C.min–1 to 800°C in air using a derivatograph Q-1500 D device. In the first step of thermal decomposition pyrazine-2-carboxamide is released (291 °C, exothermal process) and copper(I) iodide is formed. At 381°C γ-CuI with the sphalerite structure is exothermically transformed to β-CuI adopting wurtzite structure (Wells, 1975). Finally copper(I) iodide is oxidized to copper(II) oxide and molecular iodine is released at 487°C.
Crystal data, data collection and structure
details are summarized in Table 1. All non-H atoms were refined anisotropically as free atoms. The H atoms were all located in a difference map, but those attached to carbon atoms were repositioned geometrically. The H atoms were initially refined with soft restraints on the bond lengths and angles to regularize their geometry (C—H in the range 0.93–0.98, N—H in the range 0.86–0.89) and Uiso(H) (in the range 1.2–1.5 times Ueq of the parent atom), after which the positions were refined with riding constraints (Cooper et al., 2010).Copper(I) coordination polymers are well known for their photochemical and photophysical properties. There are several methods for the synthesis of such metal-organic frameworks (Peng et al., 2010). One possible strategy is the use of copper(I) halide, especially iodide, which dissolves in concentrated aqueous solutions of iodides. After addition of an organic ligand polynuclear copper(I) complexes can be crystallized (Peng et al., 2006; Feng et al., 2006; Wu et al., 2005; Rath & Holt, 1985; Rath et al., 1986).
Pyrazine-2-carboxamide (usually pyrazinamide, in medical literature abbreviated as PZA) is a drug used for tuberculosis treatment in the last 60 years. Nowadays the possibility of increasing the activity of the drug by forming transition metal complexes is examinated widely (Somoskovi et al., 2004). In addition to complexes with transition metals with potential biological effects, e.g. Mn(II), Ni(II), Fe(II), Zn(II), Cu(II) (Singh & Seth 1975; Azizov et al., 1978; Goher & Mautner, 2000) the complexes with Cu(I) have also been prepared. They have been found to be water-insoluble stable compounds with and expected polymeric structure, as has been confirmed by X–ray structure analysis of six compounds with simplified formulas [Cu2(µ-PZA)3]n(ClO4)2.C3H6O, [Cu2(µ-PZA)2(µ-C3H6O)]n(BF4)2 (Munakata et al., 1997); [Cu(µ-N3)PZA2]n (Goher & Mautner, 1999); [Cu(µ-I)PZA2]n (Goher & Mautner, 2000); [Cu(µ-CN)PZA2]n and [Cu(µ-SCN)PZA2]n (Goher & Mautner, 2001).
Goher & Mautner (2000) have succesfully prepared eleven new pyrazine-2-carboxamide complexes of Cu(I) including [CuI(pyrazine-2-carboxamide)]n, (I), but which was only obtained as a powder sample. We have successfully optimised the preparation process of (I) as well as other copper(I) complexes to obtain crystalline samples suitable for single crystal X-ray
and the of (I) is reported here.As shown in Fig. 1, the
of (I) consists of one copper(I) cation bonded to one iodide anion and one pyrazine-2-carboxamide ligand. This unit is an elementary building block of catenary polymer as depicted in Fig. 2. The CuI is coordinated by one N atom from pyrazine-2-carboxamide ligand and three I– anions to form a distorted tetrahedral coordination environment, where the Cu—N bond length is 2.059 (3) Å and the Cu—I bond lengths are 2.6016 (5), 2.6437 (5) and 2.6310 (5) Å. The Cu—N bond length is similar to the mean value of Cu—N bond lengths in above mentioned complexes (2.048 Å). There is a number of structures containing a similar ladder–like linkage of {CuNI3} tetrahedrons. In most cases one of the Cu—I bond lengths tends to be shorter then the other two, e.g. in the realated compound [Cu2(µ3-I)2(4-(4-carboxyphenyl)pyridine-N)2]n the Cu—I bond lengths are 2.631 (1), 2.662 (1), 2.667 (1) and 2.604 (1), 2.658 (1), 2.662 (1) Å (Jia et al., 2009). The I—Cu—N bond angles are 105.07 (8), 114.64 (8) and 103.54 (8)°. The distance between two CuI centres 2.7974 (6) Å indicates that there there could be a weak metal—metal interaction as the sum of van der Waals radii of two copper atoms is 2.8 Å (Bondi, 1964).The polymeric chains running in the b axis direction are connected via hydrogen bonds between the pyrazinamide ligands (Fig. 3). The amide groups of the ligands form typical dimers consisting of eight-membered rings with the graph set R22(8) linked by a strong N–H···O hydrogen bond. The second hydrogen atom of the –NH2 group forms medium N–H···N hydrogen bond to the non-coordinating N atom of the pyrazine ring, thus forming a ten-membered ring with the graph set R22(10) (Table 2.) (Bernstein et al. 1995).
Moreover, there is a weak π–π interaction between adjacent pyrazine rings in the polymer chain. The distance between two parallel planes of the rings is 3.5476 (14) Å and the centroid-centroid contact is 4.080 (2) Å (Fig. 4). The angle α between the ring normal and the centroid-centroid vector is 29.6 ° and the horizontal displacement of the rings d is 2.014 Å. It is well–known that often the ring planes are offset so that a ring atom lies almost over the center of the other ring and its hydrogen atom almost on the top of a carbon atom (Janiak, 2000). In the compound (I) this is not the case.
There are 9 compounds with the same ladder–like polymeric structure and pyrazine derivatives as the ligands in the CSD (Allen, 2002). The relevant parameters of the π–π interaction of these compounds compared to compound (I) are listed in Table 3. The entries DINQOG, GABHOH and ODOFOC correspond to the compounds with general formula [CuI(2-sub-pyrazine)]n, where sub is cyano–, iodo– and chloro– respectively. More complicated substituents on the pyrazine ring obviously lead to an increasing α angle and displacement d. Interestingly, in the case of non–substituted pyrazine the two parameters are similar to those of compound (I).
Compound (I) is stable in air and insoluble in water and most solvents, it is only sparingly soluble in dimethylsulfoxide forming a pale orange solution. We performed a thermal decompostion analysis and we found that, surprisingly, the decomposition takes place at a quite high temperature (291 °C) starting with the release of pyrazine-2-carboxamide. The
analysis of (I) clearly elucidates that the organic molecule is well–anchored not only via covalent bonding to the copper(I) center but also via non-covalent interactions between pyrazine-2-carboxamide molecules. Thanks to the thermal stability and the photoluminiscence properties of (I) described in (Goher & Mautner, 2000) the compound is a possible candidate for the use as a photoactive material.For other CuI coordination polymers, see: Peng et al. (2006, 2010); Feng et al. (2006); Wu et al. (2005); Rath & Holt (1985); Rath et al. (1986). For complexes of pyrazine-2-carboxamide with other transition metals and studies of their biological activity, see: Somoskovi et al. (2004); Singh & Seth (1975); Azizov et al. (1978). For other CuI complexes of pyrazine-2-carboxamide, see: Munakata et al. (1997); Goher & Mautner (1999, 2000, 2001). For a description of the Cambridge Structural Database, see: Allen (2002). For non-covalent interactions , see: Bernstein et al. (1995); Bondi (1964); Janiak (2000); Jia et al. (2009); Wells (1975). For the riding constraints used in the
see: Cooper et al. (2010).Data collection: CrysAlis PRO (Agilent, 2012); cell
CrysAlis PRO (Agilent, 2012); data reduction: CrysAlis PRO (Agilent, 2012); program(s) used to solve structure: SUPERFLIP (Palatinus & Chapuis, 2007); program(s) used to refine structure: CRYSTALS (Betteridge et al., 2003); molecular graphics: DIAMOND (Brandenburg, 1999), Mercury (Macrae et al., 2006) and ORTEP-3 for Windows (Farrugia, 2012); software used to prepare material for publication: CRYSTALS (Betteridge et al., 2003), PLATON (Spek, 2009) and publCIF (Westrip, 2010).[CuI(C5H5N3O)] | F(000) = 1168 |
Mr = 313.56 | Dx = 2.599 Mg m−3 |
Monoclinic, C2/c | Mo Kα radiation, λ = 0.71073 Å |
Hall symbol: -C 2yc | Cell parameters from 6637 reflections |
a = 29.5408 (7) Å | θ = 2–30° |
b = 4.0795 (1) Å | µ = 6.52 mm−1 |
c = 14.3164 (3) Å | T = 100 K |
β = 111.712 (3)° | Needle, red |
V = 1602.89 (7) Å3 | 0.22 × 0.06 × 0.03 mm |
Z = 8 |
Agilent SuperNova diffractometer | 2135 independent reflections |
Radiation source: SuperNova (Mo) X-ray Source | 1339 reflections with I > 2σ(I) |
Mirror monochromator | Rint = 0.024 |
Detector resolution: 10.3801 pixels mm-1 | θmax = 29.2°, θmin = 2.9° |
ω scans | h = −40→37 |
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2012) | k = −5→5 |
Tmin = 0.562, Tmax = 1.000 | l = −19→14 |
11538 measured reflections |
Refinement on F2 | Primary atom site location: iterative |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.021 | Hydrogen site location: difference Fourier map |
wR(F2) = 0.042 | H-atom parameters constrained |
S = 1.00 | Method = Modified Sheldrick w = 1/[σ2(F2) + 6.36P] where P = (max(Fo2,0) + 2Fc2)/3 |
1556 reflections | (Δ/σ)max = 0.001 |
100 parameters | Δρmax = 0.96 e Å−3 |
0 restraints | Δρmin = −0.87 e Å−3 |
[CuI(C5H5N3O)] | V = 1602.89 (7) Å3 |
Mr = 313.56 | Z = 8 |
Monoclinic, C2/c | Mo Kα radiation |
a = 29.5408 (7) Å | µ = 6.52 mm−1 |
b = 4.0795 (1) Å | T = 100 K |
c = 14.3164 (3) Å | 0.22 × 0.06 × 0.03 mm |
β = 111.712 (3)° |
Agilent SuperNova diffractometer | 2135 independent reflections |
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2012) | 1339 reflections with I > 2σ(I) |
Tmin = 0.562, Tmax = 1.000 | Rint = 0.024 |
11538 measured reflections |
R[F2 > 2σ(F2)] = 0.021 | 0 restraints |
wR(F2) = 0.042 | H-atom parameters constrained |
S = 1.00 | Δρmax = 0.96 e Å−3 |
1556 reflections | Δρmin = −0.87 e Å−3 |
100 parameters |
Experimental. Absorption correction: CrysAlis PRO (Agilent, 2012) Empirical absorption correction using spherical harmonics, implemented in SCALE3 ABSPACK scaling algorithm. |
x | y | z | Uiso*/Ueq | ||
I1 | 0.220190 (8) | 0.31394 (6) | 0.101635 (17) | 0.0111 | |
Cu1 | 0.268365 (16) | 0.80730 (12) | 0.20718 (3) | 0.0128 | |
N1 | 0.33830 (11) | 0.8564 (7) | 0.2104 (2) | 0.0107 | |
C2 | 0.37134 (13) | 1.0182 (9) | 0.2869 (3) | 0.0127 | |
C1 | 0.41814 (13) | 1.0748 (9) | 0.2896 (3) | 0.0111 | |
N2 | 0.43237 (11) | 0.9779 (7) | 0.2156 (2) | 0.0142 | |
C4 | 0.39912 (14) | 0.8216 (10) | 0.1390 (3) | 0.0156 | |
C3 | 0.35231 (13) | 0.7580 (8) | 0.1366 (3) | 0.0117 | |
C5 | 0.45324 (13) | 1.2545 (8) | 0.3789 (3) | 0.0123 | |
O1 | 0.43762 (9) | 1.3879 (7) | 0.4387 (2) | 0.0187 | |
N3 | 0.49934 (11) | 1.2586 (7) | 0.3874 (2) | 0.0171 | |
H21 | 0.3625 | 1.0951 | 0.3397 | 0.0157* | |
H41 | 0.4076 | 0.7545 | 0.0853 | 0.0177* | |
H31 | 0.3305 | 0.6449 | 0.0825 | 0.0152* | |
H311 | 0.5204 | 1.3547 | 0.4365 | 0.0212* | |
H312 | 0.5094 | 1.1527 | 0.3464 | 0.0198* |
U11 | U22 | U33 | U12 | U13 | U23 | |
I1 | 0.01335 (12) | 0.00921 (12) | 0.00965 (12) | −0.00022 (11) | 0.00295 (9) | −0.00083 (11) |
Cu1 | 0.0102 (2) | 0.0136 (2) | 0.0134 (2) | −0.0017 (2) | 0.00299 (18) | −0.0011 (2) |
N1 | 0.0123 (16) | 0.0075 (16) | 0.0123 (16) | −0.0001 (13) | 0.0044 (13) | 0.0031 (13) |
C2 | 0.0143 (19) | 0.012 (2) | 0.0126 (19) | 0.0009 (16) | 0.0056 (16) | 0.0001 (16) |
C1 | 0.0106 (18) | 0.0130 (18) | 0.0091 (18) | 0.0028 (15) | 0.0029 (15) | 0.0056 (15) |
N2 | 0.0131 (16) | 0.0161 (18) | 0.0129 (16) | −0.0003 (14) | 0.0042 (14) | −0.0014 (14) |
C4 | 0.018 (2) | 0.0193 (19) | 0.0108 (18) | 0.0037 (18) | 0.0071 (16) | 0.0004 (18) |
C3 | 0.0113 (18) | 0.009 (2) | 0.0102 (18) | −0.0003 (14) | −0.0013 (15) | 0.0010 (14) |
C5 | 0.0119 (19) | 0.011 (2) | 0.0125 (19) | −0.0009 (14) | 0.0023 (15) | 0.0004 (15) |
O1 | 0.0128 (14) | 0.0252 (17) | 0.0194 (15) | −0.0049 (12) | 0.0074 (12) | −0.0105 (12) |
N3 | 0.0142 (17) | 0.021 (2) | 0.0162 (17) | −0.0036 (14) | 0.0056 (14) | −0.0092 (14) |
I1—Cu1i | 2.6437 (5) | C1—N2 | 1.336 (5) |
I1—Cu1ii | 2.6310 (5) | C1—C5 | 1.505 (5) |
I1—Cu1 | 2.6016 (5) | N2—C4 | 1.333 (5) |
Cu1—N1 | 2.059 (3) | C4—C3 | 1.394 (5) |
Cu1—Cu1ii | 2.7974 (6) | C4—H41 | 0.933 |
Cu1—Cu1iii | 2.7974 (6) | C3—H31 | 0.927 |
N1—C2 | 1.341 (5) | C5—O1 | 1.240 (4) |
N1—C3 | 1.331 (5) | C5—N3 | 1.321 (5) |
C2—C1 | 1.388 (5) | N3—H311 | 0.843 |
C2—H21 | 0.939 | N3—H312 | 0.866 |
Cu1i—I1—Cu1ii | 64.057 (14) | C2—N1—C3 | 116.8 (3) |
Cu1i—I1—Cu1 | 102.106 (17) | N1—C2—C1 | 121.4 (3) |
Cu1ii—I1—Cu1 | 64.633 (14) | N1—C2—H21 | 119.2 |
Cu1ii—Cu1—Cu1iii | 93.63 (3) | C1—C2—H21 | 119.4 |
Cu1ii—Cu1—I1iv | 127.34 (3) | C2—C1—N2 | 122.1 (3) |
Cu1iii—Cu1—I1iv | 57.750 (12) | C2—C1—C5 | 118.1 (3) |
Cu1ii—Cu1—I1iii | 58.193 (19) | N2—C1—C5 | 119.8 (3) |
Cu1iii—Cu1—I1iii | 57.174 (19) | C1—N2—C4 | 116.2 (3) |
I1iv—Cu1—I1iii | 114.921 (19) | N2—C4—C3 | 122.1 (3) |
Cu1ii—Cu1—I1 | 58.193 (12) | N2—C4—H41 | 118.5 |
Cu1iii—Cu1—I1 | 126.95 (3) | C3—C4—H41 | 119.3 |
I1iv—Cu1—I1 | 102.106 (17) | C4—C3—N1 | 121.4 (3) |
I1iii—Cu1—I1 | 116.38 (2) | C4—C3—H31 | 119.5 |
Cu1ii—Cu1—N1 | 127.58 (8) | N1—C3—H31 | 119.2 |
Cu1iii—Cu1—N1 | 117.90 (8) | C1—C5—O1 | 119.0 (3) |
I1iv—Cu1—N1 | 105.07 (8) | C1—C5—N3 | 116.6 (3) |
I1iii—Cu1—N1 | 103.54 (8) | O1—C5—N3 | 124.4 (3) |
I1—Cu1—N1 | 114.64 (8) | C5—N3—H311 | 120.0 |
Cu1—N1—C2 | 119.1 (2) | C5—N3—H312 | 122.1 |
Cu1—N1—C3 | 123.9 (2) | H311—N3—H312 | 117.7 |
Symmetry codes: (i) x, y−1, z; (ii) −x+1/2, y−1/2, −z+1/2; (iii) −x+1/2, y+1/2, −z+1/2; (iv) x, y+1, z. |
D—H···A | D—H | H···A | D···A | D—H···A |
N3—H311···O1v | 0.84 | 2.05 | 2.883 (5) | 170 (1) |
N3—H312···N2vi | 0.87 | 2.32 | 3.124 (5) | 154 (1) |
Symmetry codes: (v) −x+1, −y+3, −z+1; (vi) −x+1, y, −z+1/2. |
Experimental details
Crystal data | |
Chemical formula | [CuI(C5H5N3O)] |
Mr | 313.56 |
Crystal system, space group | Monoclinic, C2/c |
Temperature (K) | 100 |
a, b, c (Å) | 29.5408 (7), 4.0795 (1), 14.3164 (3) |
β (°) | 111.712 (3) |
V (Å3) | 1602.89 (7) |
Z | 8 |
Radiation type | Mo Kα |
µ (mm−1) | 6.52 |
Crystal size (mm) | 0.22 × 0.06 × 0.03 |
Data collection | |
Diffractometer | Agilent SuperNova |
Absorption correction | Multi-scan (CrysAlis PRO; Agilent, 2012) |
Tmin, Tmax | 0.562, 1.000 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 11538, 2135, 1339 |
Rint | 0.024 |
(sin θ/λ)max (Å−1) | 0.685 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.021, 0.042, 1.00 |
No. of reflections | 1556 |
No. of parameters | 100 |
H-atom treatment | H-atom parameters constrained |
Δρmax, Δρmin (e Å−3) | 0.96, −0.87 |
Computer programs: CrysAlis PRO (Agilent, 2012), SUPERFLIP (Palatinus & Chapuis, 2007), DIAMOND (Brandenburg, 1999), Mercury (Macrae et al., 2006) and ORTEP-3 for Windows (Farrugia, 2012), CRYSTALS (Betteridge et al., 2003), PLATON (Spek, 2009) and publCIF (Westrip, 2010).
I1—Cu1i | 2.6437 (5) | Cu1—N1 | 2.059 (3) |
I1—Cu1ii | 2.6310 (5) | Cu1—Cu1ii | 2.7974 (6) |
I1—Cu1 | 2.6016 (5) |
Symmetry codes: (i) x, y−1, z; (ii) −x+1/2, y−1/2, −z+1/2. |
D—H···A | D—H | H···A | D···A | D—H···A |
N3—H311···O1iii | 0.843 | 2.047 | 2.883 (5) | 170 (1) |
N3—H312···N2iv | 0.866 | 2.320 | 3.124 (5) | 154 (1) |
Symmetry codes: (iii) −x+1, −y+3, −z+1; (iv) −x+1, y, −z+1/2. |
CSD Identifier | Substitution on pyrazine ring | Plane–plane distance (Å) | Centroid-centroid distance (Å) | Angle α [°] | Displacement d (Å) |
AGIYEU02 | none * | 3.61 | 4.18 | 30.3 | 2.11 |
DINQOG | 2-cyano | 4.10 | 4.10 | 0 | 0 |
EMEMAK01 | 2-ethyl * | 3.54 | 4.27 | 34.0 | 2.39 |
GABHOH | 2-iodo | 3.76 | 4.18 | 26.1 | 1.84 |
LIDYAZ | 2,3-dimethyl * | 3.51 | 4.32 | 35.6 | 2.52 |
MUHQOV | 2,5-dimethyl * | 3.51 | 4.29 | 35.3 | 2.48 |
ODOFOC | 2-chloro | 3.85 | 4.11 | 20.7 | 1.46 |
RIPTOA | 2-phenoxy | 3.39 | 4.25 | 37.1 | 2.57 |
XEBMUM | 2-methyl * | 3.59 | 4.23 | 31.9 | 2.23 |
Compound (I) | 2-carboxamide | 3.55 | 4.08 | 29.6 | 2.01 |
* pyrazine ring coordinated to copper via both N atoms |
Acknowledgements
This work was supported by the Ministry of Education of the Slovak Republic (grant VEGA 1/0336/13). The authors are also grateful to Dr Bernd Schweizer, PhD (Laboratory of Organic Chemistry, ETH Zürich, Switzerland) for the X-ray diffraction measurements and thank Nadácia SPP (Scholarship Hlavička) for financial assistance.
References
Agilent (2012). CrysAlis PRO. Agilent Technologies, Yarnton, England. Google Scholar
Allen, F. H. (2002). Acta Cryst. B58, 380–388. Web of Science CSD CrossRef CAS IUCr Journals Google Scholar
Azizov, T. A., Khdzhaev, O. F. & Parpiev, N. A. (1978). Koord. Khim. 4, 1234–1237. CAS Google Scholar
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N. L. (1995). Angew. Chem. Int. Ed. 34, 1555–1573. CrossRef CAS Web of Science Google Scholar
Betteridge, P. W., Carruthers, J. R., Cooper, R. I., Prout, K. & Watkin, D. J. (2003). J. Appl. Cryst. 36, 1487. Web of Science CrossRef IUCr Journals Google Scholar
Bondi, A. (1964). J. Phys. Chem. 68, 441–452. Web of Science CrossRef CAS Google Scholar
Brandenburg, K. (1999). DIAMOND. Crystal Impact GbR, Bonn, Germany. Google Scholar
Cooper, R. I., Thompson, A. L. & Watkin, D. J. (2010). J. Appl. Cryst. 43, 1100–1107. Web of Science CrossRef CAS IUCr Journals Google Scholar
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854. Web of Science CrossRef CAS IUCr Journals Google Scholar
Feng, H., Zhou, X.-P., Wu, T., Li, D., Yin, Y.-G. & Ng, S. W. (2006). Inorg. Chim. Acta, 359, 4027–4035. Web of Science CSD CrossRef CAS Google Scholar
Goher, M. A. & Mautner, F. A. (1999). J. Chem. Soc. Dalton Trans. pp. 1535–1536. Web of Science CSD CrossRef Google Scholar
Goher, M. A. & Mautner, F. A. (2000). Polyhedron, 19, 601–606. Web of Science CSD CrossRef CAS Google Scholar
Goher, M. A. & Mautner, F. A. (2001). J. Coord. Chem. 53, 79–90. Web of Science CrossRef CAS Google Scholar
Janiak, C. (2000). J. Chem. Soc. Dalton Trans. pp. 3885–3896. Web of Science CrossRef Google Scholar
Jia, X. L., Zhou, J., Zheng, S. T. & Yang, G. Y. (2009). J. Cluster Sci. 20, 555–563. Web of Science CSD CrossRef CAS Google Scholar
Macrae, C. F., Edgington, P. R., McCabe, P., Pidcock, E., Shields, G. P., Taylor, R., Towler, M. & van de Streek, J. (2006). J. Appl. Cryst. 39, 453–457. Web of Science CSD CrossRef CAS IUCr Journals Google Scholar
Munakata, M., Wu, L. P., Kuroda-Sowa, T., Maekawa, M., Moriwaki, K. & Kitagawa, S. (1997). Inorg. Chem. 36, 5416–5418. CSD CrossRef CAS Web of Science Google Scholar
Palatinus, L. & Chapuis, G. (2007). J. Appl. Cryst. 40, 786–790. Web of Science CrossRef CAS IUCr Journals Google Scholar
Peng, R., Li, M. & Li, D. (2010). Coord. Chem. Rev. 254, 1–18. Web of Science CrossRef CAS Google Scholar
Peng, R., Li, D., Wu, T., Zhou, X.-P. & Ng, S. W. (2006). Inorg. Chem. 45, 4035–4046. Web of Science CSD CrossRef PubMed CAS Google Scholar
Rath, N. P. & Holt, E. M. (1985). J. Chem. Soc. Chem. Commun. pp. 665–667. CrossRef Web of Science Google Scholar
Rath, N. P., Holt, E. M. & Tanimura, K. (1986). J. Chem. Soc. Dalton Trans. pp. 2303–2310. CSD CrossRef Web of Science Google Scholar
Singh, P. P. & Seth, J. N. (1975). J. Inorg. Nucl. Chem. 37, 593–597. CrossRef CAS Web of Science Google Scholar
Somoskovi, A., Wade, M. M., Sun, Z. H. & Zhang, Y. (2004). J. Antimicrob. Chemother. 53, 192–196. Web of Science CrossRef PubMed CAS Google Scholar
Spek, A. L. (2009). Acta Cryst. D65, 148–155. Web of Science CrossRef CAS IUCr Journals Google Scholar
Wells, A. F. (1975). In Structural Inorganic Chemistry. Oxford University Press. Google Scholar
Westrip, S. P. (2010). J. Appl. Cryst. 43, 920–925. Web of Science CrossRef CAS IUCr Journals Google Scholar
Wu, T., Li, D. & Ng, S. W. (2005). CrystEngComm, 7, 514–518. Web of Science CSD CrossRef CAS Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
Copper(I) coordination polymers are well known for their photochemical and photophysical properties. There are several methods for the synthesis of such metal-organic frameworks (Peng et al., 2010). One possible strategy is the use of copper(I) halide, especially iodide, which dissolves in concentrated aqueous solutions of iodides. After addition of an organic ligand polynuclear copper(I) complexes can be crystallized (Peng et al., 2006; Feng et al., 2006; Wu et al., 2005; Rath & Holt, 1985; Rath et al., 1986).
Pyrazine-2-carboxamide (usually pyrazinamide, in medical literature abbreviated as PZA) is a drug used for tuberculosis treatment in the last 60 years. Nowadays the possibility of increasing the activity of the drug by forming transition metal complexes is examinated widely (Somoskovi et al., 2004). In addition to complexes with transition metals with potential biological effects, e.g. Mn(II), Ni(II), Fe(II), Zn(II), Cu(II) (Singh & Seth 1975; Azizov et al., 1978; Goher & Mautner, 2000) the complexes with Cu(I) have also been prepared. They have been found to be water-insoluble stable compounds with and expected polymeric structure, as has been confirmed by X–ray structure analysis of six compounds with simplified formulas [Cu2(µ-PZA)3]n(ClO4)2.C3H6O, [Cu2(µ-PZA)2(µ-C3H6O)]n(BF4)2 (Munakata et al., 1997); [Cu(µ-N3)PZA2]n (Goher & Mautner, 1999); [Cu(µ-I)PZA2]n (Goher & Mautner, 2000); [Cu(µ-CN)PZA2]n and [Cu(µ-SCN)PZA2]n (Goher & Mautner, 2001).
Goher & Mautner (2000) have succesfully prepared eleven new pyrazine-2-carboxamide complexes of Cu(I) including [CuI(pyrazine-2-carboxamide)]n, (I), but which was only obtained as a powder sample. We have successfully optimised the preparation process of (I) as well as other copper(I) complexes to obtain crystalline samples suitable for single crystal X-ray structure determination and the crystal structure of (I) is reported here.
As shown in Fig. 1, the asymmetric unit of (I) consists of one copper(I) cation bonded to one iodide anion and one pyrazine-2-carboxamide ligand. This unit is an elementary building block of catenary polymer as depicted in Fig. 2. The CuI is coordinated by one N atom from pyrazine-2-carboxamide ligand and three I– anions to form a distorted tetrahedral coordination environment, where the Cu—N bond length is 2.059 (3) Å and the Cu—I bond lengths are 2.6016 (5), 2.6437 (5) and 2.6310 (5) Å. The Cu—N bond length is similar to the mean value of Cu—N bond lengths in above mentioned complexes (2.048 Å). There is a number of structures containing a similar ladder–like linkage of {CuNI3} tetrahedrons. In most cases one of the Cu—I bond lengths tends to be shorter then the other two, e.g. in the realated compound [Cu2(µ3-I)2(4-(4-carboxyphenyl)pyridine-N)2]n the Cu—I bond lengths are 2.631 (1), 2.662 (1), 2.667 (1) and 2.604 (1), 2.658 (1), 2.662 (1) Å (Jia et al., 2009). The I—Cu—N bond angles are 105.07 (8), 114.64 (8) and 103.54 (8)°. The distance between two CuI centres 2.7974 (6) Å indicates that there there could be a weak metal—metal interaction as the sum of van der Waals radii of two copper atoms is 2.8 Å (Bondi, 1964).
The polymeric chains running in the b axis direction are connected via hydrogen bonds between the pyrazinamide ligands (Fig. 3). The amide groups of the ligands form typical dimers consisting of eight-membered rings with the graph set R22(8) linked by a strong N–H···O hydrogen bond. The second hydrogen atom of the –NH2 group forms medium N–H···N hydrogen bond to the non-coordinating N atom of the pyrazine ring, thus forming a ten-membered ring with the graph set R22(10) (Table 2.) (Bernstein et al. 1995).
Moreover, there is a weak π–π interaction between adjacent pyrazine rings in the polymer chain. The distance between two parallel planes of the rings is 3.5476 (14) Å and the centroid-centroid contact is 4.080 (2) Å (Fig. 4). The angle α between the ring normal and the centroid-centroid vector is 29.6 ° and the horizontal displacement of the rings d is 2.014 Å. It is well–known that often the ring planes are offset so that a ring atom lies almost over the center of the other ring and its hydrogen atom almost on the top of a carbon atom (Janiak, 2000). In the compound (I) this is not the case.
There are 9 compounds with the same ladder–like polymeric structure and pyrazine derivatives as the ligands in the CSD (Allen, 2002). The relevant parameters of the π–π interaction of these compounds compared to compound (I) are listed in Table 3. The entries DINQOG, GABHOH and ODOFOC correspond to the compounds with general formula [CuI(2-sub-pyrazine)]n, where sub is cyano–, iodo– and chloro– functional group respectively. More complicated substituents on the pyrazine ring obviously lead to an increasing α angle and displacement d. Interestingly, in the case of non–substituted pyrazine the two parameters are similar to those of compound (I).
Compound (I) is stable in air and insoluble in water and most solvents, it is only sparingly soluble in dimethylsulfoxide forming a pale orange solution. We performed a thermal decompostion analysis and we found that, surprisingly, the decomposition takes place at a quite high temperature (291 °C) starting with the release of pyrazine-2-carboxamide. The crystal structure analysis of (I) clearly elucidates that the organic molecule is well–anchored not only via covalent bonding to the copper(I) center but also via non-covalent interactions between pyrazine-2-carboxamide molecules. Thanks to the thermal stability and the photoluminiscence properties of (I) described in (Goher & Mautner, 2000) the compound is a possible candidate for the use as a photoactive material.